FREDERICK, MD., (April 29, 2025) —RoosterBio, Inc., a leading supplier of adult human mesenchymal stem/stromal cells (hMSCs), highly engineered media, and bioprocess development services, announced a new collaboration with Thermo Fisher Scientific, the world leader in serving science. This collaboration aims to accelerate the availability of new, potentially life-saving cell and exosome therapies that have the potential to revolutionize the treatment of degenerative disease. [Read more…]
Key Strategies for Positioning Cell Therapy CDMO Services – Size & Specificity
A contract development and manufacturing organization (CDMO), is a company that serves cell therapy companies on a contract basis. Common cell therapy CDMO services include cell therapy product development, manufacturing, clinical trial support, and commercial supply.
CDMOs allows cell therapy companies to outsource aspects of their business, which can support:
- Scalability
- Speed to market
- Adding technical expertise without overhead costs
- Cost efficiencies
Academic and Medical CDMOs Serving the Cell Therapy Industry
In addition to commercial cell therapy CDMOs, there are other industry players that support the cell therapy industry, including academic and medical CDMOs. While these groups do contribute to the cell therapy CDMO market, their manufacturing capabilities are limited in scale and best suited to small, early-stage clinical trials. [Read more…]
Do Stem Cell Treatments For Arthritis Work?
Can stem cell treatments for arthritis bring relief to those suffering from the disease? For all of human time, the swelling and aching of joints has been a common experience. As connective tissue breaks down over time, the result is stiffening, pain, and immobility. The three most common causes of arthritis include joint injuries, age-related wear and tear, and autoimmune disorders. While some people are luckier than others, few people seem to escape it entirely, which is why stem cell treatments for arthritis are intriguing to so many.
Today, the most common kinds of arthritis are osteoarthritis (OA), rheumatoid arthritis (RA), and psoriatic arthritis (PA).
Because BioInformant is a publisher of stem cell industry news, we understandably don’t offer stem cell treatments. However, our Founder is a stem cell patient, and as a company of analysts, we do our best to track this evolving industry. With this context, let’s dive into how stem cells are currently being utilized for the treatment of arthritis in novel and intriguing ways.
Cell Therapy in Asia Erupts with Partnerships and Joint Ventures
Cell therapy in Asia has been gathering momentum over the past several years. Japan accelerated its position as a hub for regenerative medicine research, largely driven by support from Prime Minister Shinzo Abe, who identified regenerative medicine and cellular therapy as key to the Japan’s strategy to drive economic growth.
China, South Korea, and other Asian nations have also taken measures to support cell therapy development within their borders. [Read more…]
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- 6
- …
- 18
- Next Page »